- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials Sponsored by Bioven Europe
Total 4149 results
-
BiogenCompleted
-
BiogenWithdrawnRelapsing-Remitting Multiple Sclerosis (RRMS)
-
BiogenTerminatedRheumatoid ArthritisArgentina, Brazil, Hungary, Mexico, Poland, Romania, Russian Federation, United Kingdom
-
BiogenTerminatedRheumatoid ArthritisUnited States
-
BiogenCompletedMultiple SclerosisBelgium
-
BiogenCompletedHealthyUnited States, Italy, France
-
BiogenTerminatedChronic Lymphocytic LeukemiaFrance, United States, Belgium, Australia, Austria, Poland, Canada, United Kingdom
-
BiogenCompletedChronic Lymphocytic LeukemiaUnited States
-
BiogenCompleted
-
BiogenCompletedSciatica | Radiculopathy | Painful Lumbar RadiculopathyUnited States
-
BiogenCompletedMultiple SclerosisGermany
-
BiogenCompleted
-
BiogenCompletedRelapsing Multiple SclerosisUnited States, Germany, Russian Federation, India, New Zealand, Spain, Belgium, Colombia, Canada, Bulgaria, Serbia, Greece, Peru, Ukraine, Poland, United Kingdom, Croatia, France, Romania, Chile, Czech Republic, Mexico, Estonia, Georgia, Latv... and more
-
BiogenTerminated
-
BiogenCompletedMultiple SclerosisSweden, France, United Kingdom, Germany, Denmark, Netherlands, Slovakia, Switzerland, Norway, Portugal
-
BiogenCompletedMultiple Sclerosis | Pregnancy | Prenatal Exposure Delayed EffectsUnited States
-
BiogenTerminatedMultiple SclerosisUnited States
-
BiogenCompleted
-
BiogenCompletedHepatocellular CarcinomaUnited States, Singapore, Taiwan, United Kingdom
-
BiogenCompletedRheumatoid ArthritisCzech Republic, Poland, Slovakia, India, Australia, Canada
-
BiogenCompletedChronic Lymphocytic LeukemiaUnited States
-
BiogenCompletedNon-Small Cell Lung CancerUnited States
-
BiogenTerminatedMultiple SclerosisUnited States
-
BiogenCompleted
-
BiogenCompletedHealthy VolunteersUnited States
-
BiogenCompletedChronic Inflammatory Demyelinating PolyradiculoneuropathyUnited States, Australia, Canada, United Kingdom
-
BiogenCompletedNon-Hodgkin's LymphomaSweden, Czech Republic, France, Russian Federation, Turkey, United Kingdom, Germany, Lithuania, Romania, United States, Austria
-
BiogenCompletedLymphoma | TumorsUnited Kingdom, United States
-
BiogenCompletedColorectal Carcinoma | MetastasesUnited States
-
BiogenTerminatedRelapsing Remitting Multiple SclerosisAustralia
-
BiogenCompletedRelapsing-Remitting Multiple SclerosisFinland
-
BiogenCompletedRheumatoid ArthritisPoland, United States
-
BiogenCompletedMultiple SclerosisUnited States
-
NightstaRx Ltd, a Biogen CompanyCompletedChoroideremiaFinland, United States, Canada, Denmark, Netherlands, Germany, United Kingdom, Brazil, France
-
BiogenBiogen Idec A/SCompletedExerciseSweden, Finland, New Zealand, Denmark, Norway, Australia
-
BiogenAbbVieTerminatedMultiple Sclerosis | Relapsing-Remitting Multiple SclerosisUnited States, Denmark, Italy, United Kingdom, Czechia, Canada, Hungary, Spain, Australia, Israel, Georgia, Serbia, Russian Federation, Ukraine, India, Poland, Brazil, France, Argentina, Germany, Greece, Ireland, Mexico, Moldova, Republic... and more
-
Lynkcell EuropeEnrolling by invitationBreast Cancer | Breast Neoplasms | Ovarian Neoplasms | Ovarian Cancer | HER2-positive Breast Cancer | HER2-negative Breast Cancer | HER-2 Protein Overexpression | BRCA MutationUkraine
-
Metagenics EuropeTerminated
-
AOSpine EuropeCompletedAcute Spinal Cord Injury of Traumatic Origin (tSCI)United Kingdom, Ireland, Austria, Italy, Netherlands, Bulgaria, Croatia, France, Germany, Romania, Serbia, Turkey
-
Lynkcell EuropeAvailableKidney Cancer | Clear Cell Kidney Cancer | Kidney Cancer With PBRM1/BAP1/VHL/SETD2 Mutations
-
NightstaRx Ltd, a Biogen CompanyEnrolling by invitationChoroideremia | X-Linked Retinitis PigmentosaUnited States, United Kingdom, Netherlands, Germany, France, Brazil, Canada, Denmark, Finland
-
NightstaRx Ltd, a Biogen CompanyCompletedX-Linked Retinitis PigmentosaUnited States, France, United Kingdom, Finland, Netherlands, Germany, Canada
-
BiogenAbbVieCompletedRelapsing-Remitting Multiple SclerosisCzech Republic, Poland, Russian Federation, United Kingdom, Hungary, Ukraine, Germany, India